臺灣粒子治療的現況與展望

Current Status and Prospects of Particle Therapy in Taiwan

臺灣在放射腫瘤治療領域發展迅速，已引進多種先進的放射治療技術。自2015年以來，臺灣的粒子治療中心數量逐年增加，目前已有5家質子中心和1家重粒子中心，並計劃在未來五年內增設更多中心，以促進合理分佈。此外，分子放射治療技術如硼中子捕獲治療也在臺灣逐步發展，第一臺加速器硼中子捕獲治療系統於2024年啟用，使臺灣成為全球少數同時擁有多種粒子治療技術的國家。隨著各種治療技術的專業化，未來將根據腫瘤特性選擇最適合的治療方式。臺灣的粒子治療發展應以「國家隊」模式推動國際合作，透過跨中心的臨牀試驗計畫，提升國際競爭力。總體而言，臺灣在放射治療的技術創新和個性化應用上，取得顯著成就，為腫瘤病人帶來更好的治療效果和生活品質。

Taiwan has made rapid advancements in radiation oncology, introducing various cutting-edge radiation therapy technologies. Since 2015, the number of particle therapy centers in Taiwan has steadily increased. Currently, there are five proton therapy centers and one heavy particle therapy center, with plans to establish more in the next five years to promote a balanced distribution. Additionally, molecular radiotherapy technologies, such as boron neutron capture therapy (BNCT), are gradually developing. Taiwan's first accelerator-based BNCT system was launched in 2024, making it one of the few countries worldwide to possess multiple particle therapy technologies simultaneously. As treatment technologies become more specialized, the most suitable approach will be selected based on tumor characteristics. Taiwan’s particle therapy development should adopt a ''national team'' model to drive international collaboration and enhance global competitiveness through cross-center clinical trial programs. Overall, Taiwan has achieved remarkable progress in technological innovation and personalized radiotherapy, bringing better treatment outcomes and improved quality of life for cancer patients.